Searchable abstracts of presentations at key conferences in endocrinology

ea0070ep51 | Adrenal and Cardiovascular Endocrinology | ECE2020

ACTH-independent subclinical Cushing’s syndrome secondary to primary bilateral macronodular adrenal hyperplasia

Lavinia Popa Maria , Simona Andreea Găloiu

Introduction: Primary bilateral macronodular adrenal hyperplasia (PBMAH) is an uncommon cause (<1%) of endogenous Cushing’s syndrome (CS). Recently, due to increased number of incidental imaging findings of PBMAH, the clinical expression of the disease has changed in favor of oligosymptomatic or subclinical cases, compared to those with clinically manifest CS, or rarely with secretion of mineralocorticoids, or sex steroids.Case report: A 51-yea...

ea0070aep75 | Adrenal and Cardiovascular Endocrinology | ECE2020

Differential diagnosis of primary adrenal insufficiency in a young male with mental retardation and axonal sensorimotor polyneuropathy

Cristina Baleanu Maria , Galoiu Simona , Popa Lavinia , Margarit Emma , Constantin Marinescu Mihai , Caragheorgheopol Andra , Poiana Catalina

Introduction: Primary adrenal insufficiency (PAI) is a rare disease with a prevalence of 82–144 cases/milion. The etiology of PAI is represented primarily by autoimmune adrenalitis, followed by tuberculosis and less common by fungal infections, HIV, hemorrage in adrenal glands, certain drugs and by some genetic disorders such as Triple A syndrome (AAA), Adrenoleukodystrophy (ALD), congenital adrenal hypoplasia, congenital adrenal hyperplasia, etc.C...

ea0073pep1.4 | Presented ePosters 1: Adrenal and Cardiovascular Endocrinology | ECE2021

Adrenocortical oncocytoma in a patient with classic congenital adrenal hyperplasia

Baleanu Maria Cristina , Simona Andreea Găloiu , Popa Lavinia , Gherlan Iuliana , Dumitrascu Anda , Poiana Catalina

IntroductionOncocytic neoplasms arising in adrenal tissue are extremely rare with nearly 150 cases being reported in literature. They are mostly nonfunctioning benign tumors, incidentally discovered, but 20% of them demonstrate elements of malignancy and up to 30% appear to affect hormone production.Case reportA 35 years old female with primary amenorrhea, diagnosed with Congenital Adrenal Hyperplasia due to ...

ea0073aep855 | Late Breaking | ECE2021

An unusual presentation of a metastatic typical bronchial carcinoid

Lavinia Popa Maria , Găloiu Simona Andreea , Adriana Iordan Ingrid , Poiana Catalina

IntroductionLung Neuroendocrine tumors (NETs) range in aggressiveness from low-grade typical carcinoid (TC) and intermediate-grade atypical carcinoid (AC) to the high-grade large cell neuroendocrine carcinoma (LCNEC) and small cell lung carcinoma (SCLC). TC have excellent prognosis post-surgery and European Neuroendocrine Tumor Society (ENETS) recommands no adjuvant therapy for these well diferentiated tumors.Case report<p clas...

ea0090ep1132 | Late Breaking | ECE2023

Rare phenotype association between pulmonary NET and prolonged hyperkalemia after an unilateral adrenalectomy for primary hyperaldosteronism

Tănasie Denisa-Isabella , Simona Andreea Găloiu , Lavinia Popa Maria , Iordan Ingrid , Constantin Teodor , Iorgulescu Radu , Poiana Catalina

Introduction: We describe the case of a 68-year-old patient, having two MEN1-associated tumors that are not part of the classical triad, with a penetrance of only 40%, and 2%, according to the medical literature. Furthermore, she developed a persistent hyperkalemia after the unilateral adrenalectomy, which is rare and often missed.Case report: In 2011, following a non-specific symptomatology (dry cough, fatigue), a bilobectomy was performed (medium and r...

ea0070aep663 | Pituitary and Neuroendocrinology | ECE2020

Efficacy of monotherapy versus combined GH receptor antagonist therapy in patients with somatostatin receptor analogues resistant acromegaly

Simona Andreea Găloiu , Margarit Emma , Lavinia Popa Maria , Baciu Ionela , Niculescu Dan , Trifanescu Raluca , Serban Radian , Dumitrașcu Anda , Caragheorgheopol Andra , Poiana Catalina

Background and Aims: GH receptor antagonist (Pegvisomant –PEG) has been shown to obtain IGF1 normalization in 60–90% of patients with acromegaly in clinical trials. The aim of the study is to evaluate real life response and side effects of PEG treatment in monotherapy versus combined with somatostatin analogues and/or cabergoline in patients with somatostatin analogues resistant acromegaly.Methods: We included 40 patients (22F/18 M) cons...

ea0073aep659 | Thyroid | ECE2021

Outcome of Long Term Antithyroid Therapy in Patients with Graves’ Hyperthyroidism

Găloiu Simona Andreea , Lavinia Popa Maria , Margarit Emma , Baciu Ionela , Alexandru Niculescu Dan , Capatina Cristina , Trifanescu Raluca , Radian Serban , Baculescu Nicoleta , Poiana Catalina

Graves’ disease is an autoimmune thyroid disease which, untreated, carries a significant morbidity risk. Treatment options for Graves’s disease have changed over the decades.AimsTo evaluate the outcome and risk factors for relapses of patients with Graves’s disease treated with antithyroid drugs for at least 2 years.MethodsA retrospective, analytic study on 360 consecutiv...